SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following strong quarterly results and robust guidance, primarily driven by its data center business, though its after-hours performance saw an initial surge cool off. Community discussion focuses on market manipulation affecting options and a nuanced interpretation of the AI growth story, particularly after commentary on future China revenue for its advanced chips was perceived as a headwind despite the overall positive report.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending after a significant stock decline driven by softer-than-expected Q1 revenue and EBITDA guidance, despite an EPS beat for Q4. This has sparked intense debate among the community, with some investors viewing the multi-year low as a prime 'buy the dip' opportunity given strong fundamentals and buyback programs, while others express deep concern over its long-term competitive position against rivals like $ZETA and management's strategy.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending after its Q4 earnings report, which delivered strong beats on revenue and EPS, a dividend increase, and an impressive $50 billion share buyback program. Despite these positives, mixed guidance and persistent AI disruption fears for the software sector caused an initial market sell-off, leading to a contentious debate among investors.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending amid abysmal financial results and deeply negative guidance, contrasted by circulating rumors of a potential merger with Automation Anywhere. The community is sharply divided, with many dismissing the company as "garbage" despite its prime ticker, while others speculate on a short squeeze or a turnaround from merger news.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is trending after securing FDA Breakthrough Therapy Designation for its Friedreich's ataxia drug, Nomlabofusp, validating its accelerated path toward a planned 2026 BLA submission. The community is actively debating the implications of a concurrent upsized public offering, with some anticipating a short squeeze and others concerned about dilution.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is surging following its strong Q4 earnings beat and robust future revenue projections, further bolstered by securing a key position on a major government defense contract for quantum computing solutions. This news is driving spirited debate among investors, weighing the company's strategic importance and growth against its current valuation and path to profitability.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending following a mixed earnings report that beat revenue expectations but offered weaker Q1 guidance, sparking debate. While the first commercial purchase order for smart eyewear batteries is seen by some as a crucial validation of their technology, the community is actively discussing persistent delays in smartphone qualification and manufacturing yield challenges, leading to significant investor frustration and a divided outlook.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amidst mixed Q4 earnings, the announced retirement of CEO Doug Ingram, and the commercial launch of Elevidys in Japan. The community is highly focused on potential buyout opportunities and the stock's perceived undervaluation given its nearly $2 billion in annual revenue and robust pipeline, with many frustrated by persistent short-seller activity.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending following stronger-than-expected Q4 earnings, significant progress in FAA certification, and the launch of its Uber Air booking service in Dubai, signaling a major step towards commercial eVTOL operations. Despite initial concerns over a recent capital raise aimed at funding manufacturing scale-up, the community is focused on robust partnerships with Toyota and Uber, along with expanding military applications, as key drivers for its long-term growth in the burgeoning air mobility sector.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is currently trending as its strategic investment in AI powerhouse Anthropic is gaining significant market attention and value, complemented by recent analyst upgrades, sparking renewed bullish sentiment and a notable breakout in the stock price.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Benitec Biopharma (NASDAQ:BNTC) Shares Cross Below 50-Day Moving Average - Here's Why

Benitec Biopharma (NASDAQ:BNTC) Share Price Passes Below 50-Day Moving Average - Time to Sell...

Wall Street Zen Downgrades Benitec Biopharma (NASDAQ:BNTC) to Sell

Wall Street Zen downgraded Benitec Biopharma from a "hold" rating to a "sell" rating in a research note on Saturday...

Benitec Biopharma (NASDAQ:BNTC) Announces Quarterly Earnings Results

Benitec Biopharma (NASDAQ:BNTC - Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, missing...

Benitec Biopharma (BNTC) Projected to Post Earnings on Friday

Benitec Biopharma (NASDAQ:BNTC) will be releasing its Q2 2026 earnings before the market opens on Friday, February 13. (View Earnings Report at...

Benitec Biopharma Limited (NASDAQ:BNTC) Sees Large Increase in Short Interest

Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totaling 1,963,460 shares, a...

Benitec Biopharma (NASDAQ:BNTC) Director Buys $1,040,081.28 in Stock

Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L acquired 77,387 shares of the business's stock in a transaction that occurred on Monday, December...

Benitec Biopharma (NASDAQ:BNTC) Director Purchases $220,551.60 in Stock

Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 16,836 shares of the business's stock in a transaction on Friday, December 26th. The shares...

Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Purchases 50,000 Shares of Stock

Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 50,000 shares of the stock in a transaction dated Tuesday, December 23rd. The shares were...

Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock

Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

Current Price	$11.00
Prev Close	$11.12
Open	$11.05
Dividend Yield	0.00%
50-Day Moving Average	$12.02
Beta	0.48
Avg. Volume	128,103.20
PE Ratio	-11.96

52-Week High	$17.15
52-Week Low	$9.85
Market Capitalization	$382.02M
EPS (Annual)	-$1.05
Price to Book	2.03
Revenue Per Employee	$0.00

BNTC
Benitec Biopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BNTC News

BNTCBenitec Biopharma Inc